Soluble guanylate cyclase modulators

Intervention

1 paper2 findings

  • 1 lab in 1 country
  • Funder: ZonMw

Outcomes

2

ACh-induced vasorelaxation

no changein other1

1 study
  1. Soluble guanylate cyclase modulators have no effect on ACh-induced vasorelaxation in other (0.45 [-0.23; 1.13]).

    “without significantly affecting ACh-induced vasorelaxation (0.45 [-0.23; 1.13], n = 3).”

    Reviewin aged animal models of vascular dysfunction

    Targeting the NO-cGMP axis in age-related vascular dysfunction: a systematic review and meta-analysis of preclinical animal studies

    GeroScience4 Aug 2026

Microvascular perfusion

upin other1

1 study
  1. Soluble guanylate cyclase modulators improve microvascular perfusion in other (1.12 [0.46; 1.78]).

    “Similarly, sGC modulators improved microvascular perfusion (1.12 [0.46; 1.78], n = 2)”

    Reviewin aged animal models of vascular dysfunction

    Targeting the NO-cGMP axis in age-related vascular dysfunction: a systematic review and meta-analysis of preclinical animal studies

    GeroScience4 Aug 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months